Authors:
Monali Tayade, Jignesh Rawal
Download free PDF
RNA Therapeutics Market Size & Share 2024 – 2032
Report ID: GMI8053
|
Published Date: February 2024
|
Report Format: PDF/Excel/Dashboard/Platform
Download Free PDF
Explore Our Licensing Options:
Jump to Content
Market Size
Market Trends
Market Analysis
Market Share
Market Companies
Industry News
Table of Contents
Frequently Asked Questions
Research Methodology
Related Reports
Download Free PDF
RNA Therapeutics Market
Get a free sample of this report
Get a free sample of this report RNA Therapeutics Market
Is your requirement urgent? Please give us your business email
for a speedy delivery!
RNA Therapeutics Market Size
RNA Therapeutics Market size was valued at USD 19.2 billion in 2023 and is estimated to grow at a CAGR of 5.7% from 2024 to 2032. The rising incidence of infectious diseases has propelled the demand for innovative and targeted treatment options, with RNA therapeutics emerging as a promising solution.
RNA Therapeutics Market Key Takeaways
Similarly, increasing incidence of rare diseases and genetic disorders has fuelled the demand for personalized medicine, where RNA therapies play a pivotal role. For instance, as per WHO, genetic disorders and congenital abnormalities occur in about 2%-5% of all live births and account for up to 30% of paediatric hospital admissions in industrialized countries. This high incidence of genetic disorders contributes to an increased demand for new therapeutic interventions, thereby fostering the market expansion.
Additionally, the success of RNA-based COVID-19 vaccines has highlighted the potential of RNA therapeutics, garnering significant attention and investment. Thus, as the field continues to mature, the RNA therapeutics market is poised for continued growth.
RNA therapeutics refers to a class of medical interventions that utilize ribonucleic acid (RNA) molecules to treat or prevent diseases. RNA, a molecule involved in the expression of genetic information, plays a crucial role in the synthesis of proteins in cells. RNA therapeutics hold promise for treating a wide range of diseases, including genetic disorders, cancer, infectious diseases, and various other conditions.
RNA Therapeutics Market Trends
However, the intricate nature of RNA-based drugs, including the need for advanced technologies and specialized expertise, contributes to elevated development costs. Additionally, manufacturing RNA therapeutics involves sophisticated processes and quality control measures, further increasing production expenses.
RNA Therapeutics Market Analysis
Based on product, the RNA therapeutic market is segmented into vaccines and drugs. The vaccines segment held largest business share of 71.7% in 2023.
Based on type, the RNA therapeutics market is classified into mRNA therapeutics, RNA interference (RNAi) therapeutics, antisense oligonucleotide (ASO) therapeutics, siRNA (small interfering RNA) therapeutics, and other types. The mRNA therapeutics segment was valued at USD 12.6 billion in 2023.
Based on indications, the RNA therapeutics market is segmented into infectious diseases, hereditary/genetic diseases, autoimmune disorders, and other indications. The infectious diseases segment is anticipated to grow at a CAGR of 5.5% between 2024 and 2032 to reach USD 19.4 billion by 2032.
Based on end-use, the RNA therapeutics market is segmented into hospitals, academic & research institutes, and other end-users. The hospital segment is further divided into public and private.
In 2023, North America held a significant share of 36% in the global RNA therapeutics market.
RNA Therapeutics Market Share
The global RNA therapeutics industry is characterized by the active participation of key pharmaceutical companies and biotech firms. Leading players such as Moderna Inc., Novartis AG, and Pfizer Inc. have established themselves as major contributors to the market. These players are constantly engaging in strategic initiatives such as collaborations, partnerships, and R&D activities to again competitive advantage in the market.
RNA Therapeutics Market Companies
Foremost players operating in the RNA therapeutics industry are as mentioned below:
RNA Therapeutics Industry News:
The RNA therapeutics market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 - 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Product
Market, By Type
Market, By Indication
Market, By End-use
The above information is provided for the following regions and countries:
Table of Contents
Chapter 1 Methodology & Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2023
Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
Chapter 6 Market Estimates and Forecast, By Type, 2018 – 2032 ($ Mn)
Chapter 7 Market Estimates and Forecast, By Indication, 2018 – 2032 ($ Mn)
Chapter 8 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)
Chapter 10 Company Profiles
Don't see your key competitors?
The companies listed in this report are a curated selection - not the full competitive universe.
Our market revenue calculations use a bottom-up methodology that accounts for all players across all regions - including manufacturers, distributors, and specialists not individually profiled. The profiles section spotlights strategically significant players; it does not define the scope of our market sizing.
Your competitive landscape may also include
Free customization - up to 20% of report value
Need specific data? Request customization and get the insights tailored to your exact requirements.
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →